Yayın:
Surface chemistry dependent toxicity of inorganic nanostructure glycoconjugates on bacterial cells and cancer cell lines

dc.contributor.authorSancak, Sedanur
dc.contributor.authorYazgan, İdris
dc.contributor.authorBayarslan, Aslı Uğurlu
dc.contributor.authorAyna, Adnan
dc.contributor.authorEvecen, Senanur
dc.contributor.authorTaşdelen, Zehra
dc.contributor.authorGümüş, Abdurrahman
dc.contributor.authorSönmez, Hamide Ayçin
dc.contributor.authorDemir, Mehmet Ali
dc.contributor.authorDemir, Sosin
dc.contributor.authorBakar, Fatma
dc.contributor.authorDilek-Tepe, Hafize
dc.contributor.authorKasemets, Kaja
dc.contributor.authorOtsus, Maarja
dc.contributor.authorÇeter, Talip
dc.date.accessioned2026-01-04T17:47:23Z
dc.date.issued2023-01-01
dc.description.abstract© 2022 Elsevier B.V.Surface functionalized nanostructures have outstanding potential in biological applications owing to their target-specific design. In this study, we utilized laboratory synthesized carbohydrate-derivatives (i.e., galactose, mannose, lactose, and cellobiose derivatives) for aqueous one-pot synthesis of gold (Au) and silver (Ag) nanostructure glycoconjugates (NSs), and iron metal-organic framework glycoconjugates (FeMOFs). This work aims to test whether differences in the surface chemistry of the inorganic nanostructures play roles in revealing their toxicities towards bacterial cells and cancerous cell lines. As of the first step, biological activity of AuNSs, AgNSs, and FeMOFs were tested against a variety of gram (−) and gram (+) bacterial strains, where AgNSs possessed moderate to high antibacterial activities against all the tested bacterial strains, while AuNSs and FeMOFs showed their bacterial toxicity mostly depending on the strain. Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) determination studies were performed for the nanostructure glycoconjugates, for which μg/mL MBC values were obtained such as (Cellobiose p-aminobenzoic acid_AgNS) CBpAB_AgNS gave 50 μg/mL MBC value for P.aeruginosa and S.kentucy. The activity of selected sugar ligands and corresponding glycoconjugates were further tested on MDA-MB-231 breast cancer and A549 lung cancer cell lines, where selective anticancer activity was observed depending on the surface chemistry as well. Besides, D-penicillamine was introduced to galectin specific sugar ligand coated AuNS glycoconjugates, which showed very strong anticancer activities even at low doses. Overall, the importance of this work is that the surface chemistry of the inorganic nanostructures can be critical to reveal their toxicity towards bacterial cells and cancerous cell lines.
dc.description.urihttps://doi.org/10.1016/j.jddst.2022.104054
dc.description.urihttps://avesis.erciyes.edu.tr/publication/details/390082af-297f-4e2c-ad16-2760d7d2cfea/oai
dc.identifier.doi10.1016/j.jddst.2022.104054
dc.identifier.issn1773-2247
dc.identifier.openairedoi_dedup___::649aeb7bf1328690a12613d620bff21e
dc.identifier.orcid0000-0002-0264-1253
dc.identifier.orcid0000-0003-2131-2823
dc.identifier.orcid0000-0003-2993-5769
dc.identifier.orcid0000-0002-6035-6901
dc.identifier.orcid0000-0001-6413-3660
dc.identifier.orcid0009-0001-3000-2096
dc.identifier.orcid0000-0003-3626-1758
dc.identifier.scopus2-s2.0-85143357436
dc.identifier.startpage104054
dc.identifier.urihttps://hdl.handle.net/20.500.12597/40357
dc.identifier.volume79
dc.identifier.wos000978005400001
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.ispartofJournal of Drug Delivery Science and Technology
dc.rightsCLOSED
dc.subject.sdg3. Good health
dc.titleSurface chemistry dependent toxicity of inorganic nanostructure glycoconjugates on bacterial cells and cancer cell lines
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Sedanur Sancak","name":"Sedanur","surname":"Sancak","rank":1,"pid":null},{"fullName":"İdris Yazgan","name":"İdris","surname":"Yazgan","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0002-0264-1253"},"provenance":null}},{"fullName":"Aslı Uğurlu Bayarslan","name":"Aslı Uğurlu","surname":"Bayarslan","rank":3,"pid":{"id":{"scheme":"orcid_pending","value":"0000-0003-2131-2823"},"provenance":null}},{"fullName":"Adnan Ayna","name":"Adnan","surname":"Ayna","rank":4,"pid":null},{"fullName":"Senanur Evecen","name":"Senanur","surname":"Evecen","rank":5,"pid":null},{"fullName":"Zehra Taşdelen","name":"Zehra","surname":"Taşdelen","rank":6,"pid":null},{"fullName":"Abdurrahman Gümüş","name":"Abdurrahman","surname":"Gümüş","rank":7,"pid":{"id":{"scheme":"orcid","value":"0000-0003-2993-5769"},"provenance":null}},{"fullName":"Hamide Ayçin Sönmez","name":"Hamide Ayçin","surname":"Sönmez","rank":8,"pid":null},{"fullName":"Mehmet Ali Demir","name":"Mehmet Ali","surname":"Demir","rank":9,"pid":null},{"fullName":"Sosin Demir","name":"Sosin","surname":"Demir","rank":10,"pid":null},{"fullName":"Fatma Bakar","name":"Fatma","surname":"Bakar","rank":11,"pid":null},{"fullName":"Hafize Dilek-Tepe","name":"Hafize","surname":"Dilek-Tepe","rank":12,"pid":{"id":{"scheme":"orcid_pending","value":"0000-0002-6035-6901"},"provenance":null}},{"fullName":"Kaja Kasemets","name":"Kaja","surname":"Kasemets","rank":13,"pid":{"id":{"scheme":"orcid","value":"0000-0001-6413-3660"},"provenance":null}},{"fullName":"Maarja Otsus","name":"Maarja","surname":"Otsus","rank":14,"pid":{"id":{"scheme":"orcid","value":"0009-0001-3000-2096"},"provenance":null}},{"fullName":"Talip Çeter","name":"Talip","surname":"Çeter","rank":15,"pid":{"id":{"scheme":"orcid","value":"0000-0003-3626-1758"},"provenance":null}}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"0301 basic medicine"},"provenance":null},{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"FOS","value":"02 engineering and technology"},"provenance":null},{"subject":{"scheme":"FOS","value":"0210 nano-technology"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"Surface chemistry dependent toxicity of inorganic nanostructure glycoconjugates on bacterial cells and cancer cell lines","subTitle":null,"descriptions":["© 2022 Elsevier B.V.Surface functionalized nanostructures have outstanding potential in biological applications owing to their target-specific design. In this study, we utilized laboratory synthesized carbohydrate-derivatives (i.e., galactose, mannose, lactose, and cellobiose derivatives) for aqueous one-pot synthesis of gold (Au) and silver (Ag) nanostructure glycoconjugates (NSs), and iron metal-organic framework glycoconjugates (FeMOFs). This work aims to test whether differences in the surface chemistry of the inorganic nanostructures play roles in revealing their toxicities towards bacterial cells and cancerous cell lines. As of the first step, biological activity of AuNSs, AgNSs, and FeMOFs were tested against a variety of gram (−) and gram (+) bacterial strains, where AgNSs possessed moderate to high antibacterial activities against all the tested bacterial strains, while AuNSs and FeMOFs showed their bacterial toxicity mostly depending on the strain. Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) determination studies were performed for the nanostructure glycoconjugates, for which μg/mL MBC values were obtained such as (Cellobiose p-aminobenzoic acid_AgNS) CBpAB_AgNS gave 50 μg/mL MBC value for P.aeruginosa and S.kentucy. The activity of selected sugar ligands and corresponding glycoconjugates were further tested on MDA-MB-231 breast cancer and A549 lung cancer cell lines, where selective anticancer activity was observed depending on the surface chemistry as well. Besides, D-penicillamine was introduced to galectin specific sugar ligand coated AuNS glycoconjugates, which showed very strong anticancer activities even at low doses. Overall, the importance of this work is that the surface chemistry of the inorganic nanostructures can be critical to reveal their toxicity towards bacterial cells and cancerous cell lines."],"publicationDate":"2023-01-01","publisher":"Elsevier BV","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Journal of Drug Delivery Science and Technology","issnPrinted":"1773-2247","issnOnline":null,"issnLinking":null,"ep":null,"iss":null,"sp":"104054","vol":"79","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::649aeb7bf1328690a12613d620bff21e","originalIds":["S1773224722009650","10.1016/j.jddst.2022.104054","50|doiboost____|649aeb7bf1328690a12613d620bff21e","50|od______9447::c278c9dfc78c4100e877a5145ee3494c","390082af-297f-4e2c-ad16-2760d7d2cfea"],"pids":[{"scheme":"doi","value":"10.1016/j.jddst.2022.104054"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":4,"influence":2.6272886e-9,"popularity":5.203287e-9,"impulse":4,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1016/j.jddst.2022.104054"}],"license":"Elsevier TDM","type":"Article","urls":["https://doi.org/10.1016/j.jddst.2022.104054"],"publicationDate":"2023-01-01","refereed":"peerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.jddst.2022.104054"}],"type":"Article","urls":["https://avesis.erciyes.edu.tr/publication/details/390082af-297f-4e2c-ad16-2760d7d2cfea/oai"],"publicationDate":"2023-01-01","refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Koleksiyonlar